Washington, D.C./ Science, Tech & Medicine

ATCC Opens $55M Manassas Biomanufacturing Hub, Eyes 75 New Jobs

AI Assisted Icon
Published on November 21, 2026
ATCC Opens $55M Manassas Biomanufacturing Hub, Eyes 75 New JobsSource: Carol M. Highsmith / Wikimedia Commons

ATCC cut the ribbon Thursday on its new Centennial Biomanufacturing Center in Manassas, a 50,000-square-foot facility the nonprofit says could create up to 75 full-time jobs while ramping up production of biological materials used in infectious-disease research and public-health preparedness. The opening caps years of planning at ATCC's headquarters in Prince William County, where the organization has operated since 1998.

ATCC, short for American Type Culture Collection, describes itself as the world's largest nonprofit biological resource center, according to InsideNoVa. The new center, located at ATCC's headquarters campus, will manufacture, characterize, authenticate, store and distribute essential biomaterials for research, product development and public-health preparedness, according to a GlobeNewswire release announcing the opening. That release puts ATCC's investment at more than $55 million, supplemented by federal and state funding, though Virginia's 2024 announcement of the project through the Virginia Economic Development Partnership described the planned investment as $54.7 million — a discrepancy the available records don't explain.

Funding Drew on Federal Grants and a State Assist

Funding for the center included a National Institutes of Health research facilities construction grant and a National Institute of Allergy and Infectious Diseases grant for research capabilities and pandemic preparedness, per the seed reporting. Virginia's 2024 project announcement said the commonwealth competed with Maryland to land the project, and Governor Youngkin approved an $800,000 grant from the Commonwealth's Opportunity Fund to assist Prince William County with the effort, according to the Virginia Economic Development Partnership.

The Virginia Talent Accelerator Program will also help ATCC recruit and train workers for the facility. Virginia Deputy Secretary of Commerce and Trade Stewart Ackerly, speaking at the opening, said the facility represents collaboration and partnership, adding that the state's life sciences sector benefits from strong partnerships, InsideNoVa reported.

What the Center Will Actually Produce

Inside the new facility, ATCC plans high-throughput manufacturing and scalable production of authenticated biological materials, including research models and essential reagents. The center is expected to work with the National Institutes of Health on disease-outbreak research and to support U.S. Department of Agriculture initiatives tied to highly pathogenic avian influenza, according to the GlobeNewswire release. Initial programs also call for developing and testing human-relevant models, including lung and blood-brain barrier models, for the National Institute of Allergy and Infectious Diseases.

Those models fall under what researchers call New Approach Methodologies, which may help scientists understand disease mechanisms and evaluate potential treatments while reducing reliance on traditional animal models, per InsideNoVa. ATCC had previously secured an NIH construction grant for a biomanufacturing suite at its Manassas headquarters designed to rapidly respond to infectious disease outbreaks by providing high-throughput manufacturing for virus stocks and reagents to the NIH, according to an ATCC announcement, which also noted that requests for biomaterials have exploded exponentially since the start of the COVID-19 pandemic.

Leaders Frame the Opening as Critical Infrastructure

ATCC Senior Vice President of Federal Solutions Rebecca Bradford, who emceed the event, called the facility critical infrastructure for the nation, per InsideNoVa's account of the ribbon-cutting. ATCC President and CEO Ruth Cheng said the center will help researchers move scientific discoveries toward real-world applications, adding that laboratory validation and data can help translate research into treatments and that the center will strengthen the BioHealth Capital Region.

That region, which spans Virginia and Maryland, ranks third nationally among U.S. biopharma clusters, InsideNoVa reported. Genetic Engineering & Biotechnology News has described global biopharma companies reshoring manufacturing into emerging U.S. clusters, with new sites spreading into Maryland and Virginia alongside established hubs — a trend that includes Eli Lilly's $5 billion manufacturing facility under construction in Goochland County, west of Richmond, for its bioconjugate platform and monoclonal antibody portfolio.

Local Officials Point to Nexus234 Growth

The Centennial Biomanufacturing Center also ties into Nexus234, an innovation district created by George Mason University, Prince William County and the City of Manassas, with ATCC involved as a partner, according to Technical.ly. Prince William County Board of Supervisors Chair Deshundra Jefferson said ATCC's investment supports growth of the district, and that ATCC and the community have invested in one another over time, InsideNoVa reported. The county recognized ATCC with its 2026 Make Your Mark Economic Legacy Award the week before the center's opening.

Technical.ly noted that the projected 75 jobs compare favorably against other large development projects in the region, pointing out that a typical 250,000-square-foot data center creates an average of just 50 permanent roles. ATCC's presence in Prince William County has already contributed to job creation, the attraction of scientists and partnerships with research and educational institutions, according to InsideNoVa's reporting, which also noted that Virginia hosts six R1 research universities and 10 federally funded research and development centers statewide.